{"id":44951,"date":"2022-06-10T14:01:42","date_gmt":"2022-06-10T12:01:42","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/sparrow-pharmaceuticals-to-present-new-clinical-pharmacology-data-on-spi-62-at-the-endocrine-society-endo-2022-annual-conference\/"},"modified":"2022-06-10T14:01:42","modified_gmt":"2022-06-10T12:01:42","slug":"sparrow-pharmaceuticals-to-present-new-clinical-pharmacology-data-on-spi-62-at-the-endocrine-society-endo-2022-annual-conference","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/sparrow-pharmaceuticals-to-present-new-clinical-pharmacology-data-on-spi-62-at-the-endocrine-society-endo-2022-annual-conference\/","title":{"rendered":"Sparrow Pharmaceuticals to Present New Clinical Pharmacology Data on SPI-62 at the Endocrine Society (ENDO) 2022 Annual Conference"},"content":{"rendered":"<div>\n<p>PORTLAND, Ore.&#8211;(BUSINESS WIRE)&#8211;<a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.sparrowpharma.com%2F&amp;esheet=52745494&amp;newsitemid=20220610005100&amp;lan=en-US&amp;anchor=Sparrow+Pharmaceuticals%2C&amp;index=1&amp;md5=1fa0fe98c5d94a26f8a2601d20996e69\" rel=\"nofollow noopener\" shape=\"rect\">Sparrow Pharmaceuticals,<\/a> an emerging, clinical-stage biopharmaceutical company developing novel, targeted therapies to address unmet needs in both endocrinology and rheumatology, today announced that it will present new clinical pharmacology data at the Endocrine Society (ENDO) 2022 Annual Conference on its candidate, SPI-62, an HSD-1 inhibitor. Sparrow will present the data during an in-person poster session and a Rapid Fire e-Poster presentation. ENDO 2022 will take place June 11-14, 2022 in Atlanta, Georgia.\n<\/p>\n<p><a href=\"https:\/\/mms.businesswire.com\/media\/20220610005100\/en\/1482747\/5\/Sparrow_Logo_RGB_CORE_Horizontal.jpg\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20220610005100\/en\/1482747\/21\/Sparrow_Logo_RGB_CORE_Horizontal.jpg\"><\/a><\/p>\n<p>\nThe poster presentation session and Rapid Fire e-Poster presentation details are summarized below:\n<\/p>\n<p>\n<b><span class=\"bwuline\">ENDO 2022 Rapid Fire e-Poster Presentation<\/span><\/b>\n<\/p>\n<ul class=\"bwlistdisc\">\n<li>\n<b>Title<\/b>: HPA Axis Modulation by a Potent Inhibitor Indicates 11b-Hydroxysteroid Dehydrogenase Type 1 (HSD-1) Is a Significant Contributor to Cortisol Levels\n<\/li>\n<li>\n<b>E-Poster Number:<\/b> RF21\n<\/li>\n<li>\n<b>Presenting Authors<\/b>: David A. Katz, Ph.D. and Mark Mortier, MS\n<\/li>\n<li>\n<b>Rapid Session Date\/Time<\/b>: Sunday, June 12<sup>th<\/sup>, 2022 from 1:06pm \u2013 1:11pm ET in ENDOExpo, Pod 7\n<\/li>\n<\/ul>\n<p>\n<b><span class=\"bwuline\">ENDO 2022 In-Person Poster Presentation<\/span><\/b>\n<\/p>\n<ul class=\"bwlistdisc\">\n<li>\n<b>Title<\/b>: HPA Axis Modulation by a Potent Inhibitor Indicates 11b-Hydroxysteroid Dehydrogenase Type 1 (HSD-1) Is a Significant Contributor to Cortisol Levels\n<\/li>\n<li>\n<b>Poster Number:<\/b> PSAT100\n<\/li>\n<li>\n<b>Presenting Authors<\/b>: David A. Katz, Ph.D. and Mark Mortier, MS\n<\/li>\n<li>\n<b>Rapid Session Date\/Time<\/b>: Sunday, June 12<sup>th<\/sup>, 2022 from 1:00pm \u2013 3:00pm ET in HallA1\n<\/li>\n<\/ul>\n<p>\nTo register and view the abstracts, visit ENDO\u2019s website <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fendo2022.endocrine.org%2F&amp;esheet=52745494&amp;newsitemid=20220610005100&amp;lan=en-US&amp;anchor=here&amp;index=2&amp;md5=ef9e1ce839b94184ba26e88058a950b2\" rel=\"nofollow noopener\" shape=\"rect\">here<\/a>.\n<\/p>\n<p>\nTo learn more about Sparrow Pharmaceuticals and its leadership team, visit the website at <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.sparrowpharma.com&amp;esheet=52745494&amp;newsitemid=20220610005100&amp;lan=en-US&amp;anchor=www.sparrowpharma.com&amp;index=3&amp;md5=e3e3d96f2031d6746d383df5bcc06e7f\" rel=\"nofollow noopener\" shape=\"rect\">www.sparrowpharma.com<\/a>.\n<\/p>\n<p>\n<b>About Sparrow Pharmaceuticals<br \/>\n<br \/><\/b>Sparrow Pharmaceuticals was founded to spare patients the ravages of steroids. Leveraging underappreciated scientific insights into steroid biology, the company is working to provide better treatment options for serious disorders of hypercortisolism, and to revolutionize the treatment of autoimmune and inflammatory conditions. SPI-62, is an oral, small molecule, novel therapeutic treatment designed to target the source of active intracellular glucocorticoids in key tissues. SPI-47 is a fixed-dose-combination of SPI-62 and the glucocorticoid medicine prednisolone.\n<\/p>\n<p> <b>Contacts<\/b> <\/p>\n<p>\nAlexis Feinberg<br \/>\n<br \/>ICR Westwicke<br \/>\n<br \/><a target=\"_blank\" href=\"&#109;&#x61;i&#x6c;t&#111;&#x3a;&#65;&#x6c;e&#120;&#x69;&#115;&#x2e;F&#x65;&#x69;&#110;&#x62;e&#x72;g&#64;&#x77;&#101;&#x73;t&#119;&#x69;&#99;&#x6b;e&#46;&#x63;&#111;&#x6d;\" rel=\"nofollow noopener\" shape=\"rect\">&#65;&#x6c;&#x65;&#120;&#x69;&#x73;&#46;&#x46;&#x65;&#105;&#x6e;&#x62;&#101;&#x72;&#x67;&#64;&#x77;&#x65;&#115;&#x74;&#x77;&#105;&#x63;&#x6b;&#101;&#x2e;&#x63;o&#x6d;<\/a><br \/>203-939-2225\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>PORTLAND, Ore.&#8211;(BUSINESS WIRE)&#8211;Sparrow Pharmaceuticals, an emerging, clinical-stage biopharmaceutical company developing novel, targeted therapies to address unmet needs in both endocrinology and rheumatology, today announced that it will present new clinical pharmacology data at the Endocrine Society (ENDO) 2022 Annual Conference on its candidate, SPI-62, an HSD-1 inhibitor. Sparrow will present the data during an in-person &#8230; <span class=\"more\"><a class=\"more-link\" href=\"https:\/\/pharma-trend.com\/en\/sparrow-pharmaceuticals-to-present-new-clinical-pharmacology-data-on-spi-62-at-the-endocrine-society-endo-2022-annual-conference\/\">[Read more&#8230;]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-44951","6":"format-standard","7":"category-industry"},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Sparrow Pharmaceuticals to Present New Clinical Pharmacology Data on SPI-62 at the Endocrine Society (ENDO) 2022 Annual Conference - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/sparrow-pharmaceuticals-to-present-new-clinical-pharmacology-data-on-spi-62-at-the-endocrine-society-endo-2022-annual-conference\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Sparrow Pharmaceuticals to Present New Clinical Pharmacology Data on SPI-62 at the Endocrine Society (ENDO) 2022 Annual Conference - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"PORTLAND, Ore.&#8211;(BUSINESS WIRE)&#8211;Sparrow Pharmaceuticals, an emerging, clinical-stage biopharmaceutical company developing novel, targeted therapies to address unmet needs in both endocrinology and rheumatology, today announced that it will present new clinical pharmacology data at the Endocrine Society (ENDO) 2022 Annual Conference on its candidate, SPI-62, an HSD-1 inhibitor. Sparrow will present the data during an in-person ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/sparrow-pharmaceuticals-to-present-new-clinical-pharmacology-data-on-spi-62-at-the-endocrine-society-endo-2022-annual-conference\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2022-06-10T12:01:42+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20220610005100\/en\/1482747\/21\/Sparrow_Logo_RGB_CORE_Horizontal.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/sparrow-pharmaceuticals-to-present-new-clinical-pharmacology-data-on-spi-62-at-the-endocrine-society-endo-2022-annual-conference\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/sparrow-pharmaceuticals-to-present-new-clinical-pharmacology-data-on-spi-62-at-the-endocrine-society-endo-2022-annual-conference\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Sparrow Pharmaceuticals to Present New Clinical Pharmacology Data on SPI-62 at the Endocrine Society (ENDO) 2022 Annual Conference\",\"datePublished\":\"2022-06-10T12:01:42+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/sparrow-pharmaceuticals-to-present-new-clinical-pharmacology-data-on-spi-62-at-the-endocrine-society-endo-2022-annual-conference\\\/\"},\"wordCount\":324,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/sparrow-pharmaceuticals-to-present-new-clinical-pharmacology-data-on-spi-62-at-the-endocrine-society-endo-2022-annual-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220610005100\\\/en\\\/1482747\\\/21\\\/Sparrow_Logo_RGB_CORE_Horizontal.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/sparrow-pharmaceuticals-to-present-new-clinical-pharmacology-data-on-spi-62-at-the-endocrine-society-endo-2022-annual-conference\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/sparrow-pharmaceuticals-to-present-new-clinical-pharmacology-data-on-spi-62-at-the-endocrine-society-endo-2022-annual-conference\\\/\",\"name\":\"Sparrow Pharmaceuticals to Present New Clinical Pharmacology Data on SPI-62 at the Endocrine Society (ENDO) 2022 Annual Conference - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/sparrow-pharmaceuticals-to-present-new-clinical-pharmacology-data-on-spi-62-at-the-endocrine-society-endo-2022-annual-conference\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/sparrow-pharmaceuticals-to-present-new-clinical-pharmacology-data-on-spi-62-at-the-endocrine-society-endo-2022-annual-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220610005100\\\/en\\\/1482747\\\/21\\\/Sparrow_Logo_RGB_CORE_Horizontal.jpg\",\"datePublished\":\"2022-06-10T12:01:42+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/sparrow-pharmaceuticals-to-present-new-clinical-pharmacology-data-on-spi-62-at-the-endocrine-society-endo-2022-annual-conference\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/sparrow-pharmaceuticals-to-present-new-clinical-pharmacology-data-on-spi-62-at-the-endocrine-society-endo-2022-annual-conference\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/sparrow-pharmaceuticals-to-present-new-clinical-pharmacology-data-on-spi-62-at-the-endocrine-society-endo-2022-annual-conference\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220610005100\\\/en\\\/1482747\\\/21\\\/Sparrow_Logo_RGB_CORE_Horizontal.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220610005100\\\/en\\\/1482747\\\/21\\\/Sparrow_Logo_RGB_CORE_Horizontal.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/sparrow-pharmaceuticals-to-present-new-clinical-pharmacology-data-on-spi-62-at-the-endocrine-society-endo-2022-annual-conference\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Sparrow Pharmaceuticals to Present New Clinical Pharmacology Data on SPI-62 at the Endocrine Society (ENDO) 2022 Annual Conference\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Sparrow Pharmaceuticals to Present New Clinical Pharmacology Data on SPI-62 at the Endocrine Society (ENDO) 2022 Annual Conference - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/sparrow-pharmaceuticals-to-present-new-clinical-pharmacology-data-on-spi-62-at-the-endocrine-society-endo-2022-annual-conference\/","og_locale":"en_US","og_type":"article","og_title":"Sparrow Pharmaceuticals to Present New Clinical Pharmacology Data on SPI-62 at the Endocrine Society (ENDO) 2022 Annual Conference - Pharma Trend","og_description":"PORTLAND, Ore.&#8211;(BUSINESS WIRE)&#8211;Sparrow Pharmaceuticals, an emerging, clinical-stage biopharmaceutical company developing novel, targeted therapies to address unmet needs in both endocrinology and rheumatology, today announced that it will present new clinical pharmacology data at the Endocrine Society (ENDO) 2022 Annual Conference on its candidate, SPI-62, an HSD-1 inhibitor. Sparrow will present the data during an in-person ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/sparrow-pharmaceuticals-to-present-new-clinical-pharmacology-data-on-spi-62-at-the-endocrine-society-endo-2022-annual-conference\/","og_site_name":"Pharma Trend","article_published_time":"2022-06-10T12:01:42+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20220610005100\/en\/1482747\/21\/Sparrow_Logo_RGB_CORE_Horizontal.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/sparrow-pharmaceuticals-to-present-new-clinical-pharmacology-data-on-spi-62-at-the-endocrine-society-endo-2022-annual-conference\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/sparrow-pharmaceuticals-to-present-new-clinical-pharmacology-data-on-spi-62-at-the-endocrine-society-endo-2022-annual-conference\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Sparrow Pharmaceuticals to Present New Clinical Pharmacology Data on SPI-62 at the Endocrine Society (ENDO) 2022 Annual Conference","datePublished":"2022-06-10T12:01:42+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/sparrow-pharmaceuticals-to-present-new-clinical-pharmacology-data-on-spi-62-at-the-endocrine-society-endo-2022-annual-conference\/"},"wordCount":324,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/sparrow-pharmaceuticals-to-present-new-clinical-pharmacology-data-on-spi-62-at-the-endocrine-society-endo-2022-annual-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220610005100\/en\/1482747\/21\/Sparrow_Logo_RGB_CORE_Horizontal.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/sparrow-pharmaceuticals-to-present-new-clinical-pharmacology-data-on-spi-62-at-the-endocrine-society-endo-2022-annual-conference\/","url":"https:\/\/pharma-trend.com\/en\/sparrow-pharmaceuticals-to-present-new-clinical-pharmacology-data-on-spi-62-at-the-endocrine-society-endo-2022-annual-conference\/","name":"Sparrow Pharmaceuticals to Present New Clinical Pharmacology Data on SPI-62 at the Endocrine Society (ENDO) 2022 Annual Conference - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/sparrow-pharmaceuticals-to-present-new-clinical-pharmacology-data-on-spi-62-at-the-endocrine-society-endo-2022-annual-conference\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/sparrow-pharmaceuticals-to-present-new-clinical-pharmacology-data-on-spi-62-at-the-endocrine-society-endo-2022-annual-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220610005100\/en\/1482747\/21\/Sparrow_Logo_RGB_CORE_Horizontal.jpg","datePublished":"2022-06-10T12:01:42+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/sparrow-pharmaceuticals-to-present-new-clinical-pharmacology-data-on-spi-62-at-the-endocrine-society-endo-2022-annual-conference\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/sparrow-pharmaceuticals-to-present-new-clinical-pharmacology-data-on-spi-62-at-the-endocrine-society-endo-2022-annual-conference\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/sparrow-pharmaceuticals-to-present-new-clinical-pharmacology-data-on-spi-62-at-the-endocrine-society-endo-2022-annual-conference\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20220610005100\/en\/1482747\/21\/Sparrow_Logo_RGB_CORE_Horizontal.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20220610005100\/en\/1482747\/21\/Sparrow_Logo_RGB_CORE_Horizontal.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/sparrow-pharmaceuticals-to-present-new-clinical-pharmacology-data-on-spi-62-at-the-endocrine-society-endo-2022-annual-conference\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Sparrow Pharmaceuticals to Present New Clinical Pharmacology Data on SPI-62 at the Endocrine Society (ENDO) 2022 Annual Conference"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/44951","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=44951"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/44951\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=44951"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=44951"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=44951"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}